The Vascular Research Initiatives Conference and over 25 years of conversations on the science of vascular disease.
The Vascular Research Initiatives Conference and over 25 years of conversations on the science of vascular disease.
复制标题
血管研究倡议会议和超过 25 年的血管疾病科学对话。
DOI：
10.1016/j.jvs.2012.10.013
复制
发表时间：
2013
影响因子：
4.3
通讯作者：
Dardik,Alan
中科院分区：
文献类型：
--
作者：
Curci,JohnA;Kraiss,Larry;Dalman,RonaldL;Daugherty,Alan;Thompson,RobertW;Dardik,Alan
血管研究倡议会议 (VRIC) 是成立于 1986 年的年度会议。该会议成功地为展示和讨论与血管外科科学基础相关的高质量创新和相关研究提供了一个论坛。我们通过将年轻且更有成就的血管外科医生研究人员与其他高素质血管生物学家的广泛代表聚集在一起来实现这一目标。 VRIC 为血管外科界提供了一个独特的场所来展示血管外科医生科学家的研究成果，这些科学家是一群对血管疾病有着非凡了解的医生，他们可以直接接触患者，从而有助于获取组织标本。 VRIC 在各种血管生物学研究人员之间建立了重要的跨学科合作。血管生物学领域以目标为导向的研究进展至关重要，因为血管疾病继续影响着世界上许多人口，特别是仍然是美国公民发病和死亡的主要原因。 VRIC 的首要目标是提供一个科学论坛，用于展示、传播和批评有关血管外科疾病临床前转化研究的新数据。重点是机制研究和新治疗靶点的发现，这些靶点可能会为受影响的患者带来实际应用和治疗。这一目标是通过以下方式实现的：(1) 为旨在激发所有与会者之间建设性互动的项目选择最高质量的研究；(2) 邀请一位在血管研究领域具有杰出表现的主讲人；(3) 计划空闲时间进行非正式讨论和建立合作；(4) 与美国心脏协会 (AHA) 动脉硬化、血栓和血管生物学 (ATVB) 理事会（另一个知名的首要血管协会）的年会进行协调和协作会议安排生物学会议。
The Vascular Research Initiatives Conference (VRIC) is an annual conference established in 1986. This conference has successfully provided a forum for the presentation and discussion of high-quality innovative and relevant research related to the scientific underpinnings of vascular surgery. We have accomplished this by bringing young and more accomplished vascular surgeon researchers together with a broad representation of other high-caliber vascular biologists. The VRIC provides a unique venue for the vascular surgery community to showcase research produced by vascular surgeon scientists—a group of physicians with an exceptional understanding of vascular disease whose direct access to patients facilitates acquisition of tissue specimens. The VRIC creates important interdisciplinary collaborations among a wide variety of vascular biology investigators. Goal-directed research progress in vascular biology is critical, as vascular disease continues to affect much of the world's population and, in particular, continues to be the leading cause of morbidity and mortality for the citizens of the United States.The first aim of the VRIC is to provide a scientific forum for the presentation, dissemination, and critique of new data regarding preclinical translational research in vascular surgical diseases. There is emphasis on mechanistic studies and discoveries of novel treatment targets that may lead to practical applications and therapies for affected patients. This aim is accomplished by (1) selection of the highest-quality research for a program designed to stimulate constructive interaction between all attendees,(2) invitation of a keynote speaker with distinction in the field of vascular research,(3) planned free time for informal discussions and creation of collaborations, and (4) coordinated and collaborative meeting arrangements with the annual meeting of the Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Council of the American Heart Association (AHA), another well-established premier vascular biology meeting.